Abstract
Spinal muscular atrophy (SMA) is a genetic neuromuscular disease characterized by progressive muscle weakness and atrophy. We report a case of a 36-year-old man with SMA type 3 who presented to our emergency department with epigastric pain and vomiting. He was found to have severe ketoacidosis on laboratory evaluation. The patient’s symptoms and ketoacidosis resolved after dextrose infusion and a relatively small amount of sodium bicarbonate infusion. Given the severity of the ketosis that seemed inconsistent with moderate starvation alone, we postulate that there must have been other contributing factors besides moderate starvation that might explain the severity of acidosis in this particular patient. These factors include low muscle mass, disturbed fatty acid metabolism, hormonal imbalances and defective glucose metabolism. Ketoacidosis is an under-recognized entity in patients with neuromuscular diseases and requires a high index of suspicion for prompt diagnosis and management.
Similar content being viewed by others
References
Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011;68(8):979–84.
Darras BT. Spinal muscular atrophies. Pediatr Clin N Am. 2015;62(3):743–66.
Paulson DJ, et al. Ketogenic effects of carnitine in patients with muscular dystrophy and cytochrome oxidase deficiency. Biochem Med Metab Biol. 1988;39(1):40–7.
Mulroy E, Gleeson S, Furlong MJ. Stress-induced ketoacidosis in spinal muscular atrophy: an under-recognized complication. J Neuromuscul Dis. 2016;3(3):419–23.
Paulson DJ, Hoganson GE, Traxler J, Sufit R, Peters H, Shug AL. Ketogenic effects of carnitine in patients with muscular dystrophy and cytochrome oxidase deficiency. Biochem Med Metab Biol. 1988;39(1):40–7.
Tein I, Sloane AE, Donner EJ, Lehotay DC, Millington DS, Kelley RI. Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)? Pediatr Neurol. 1995;12(1):21–30.
Crawford TO, Sladky JT, Hurko O, Besner-Johnston A, Kelley RI. Abnormal fatty acid metabolism in childhood spinal muscular atrophy. Ann Neurol. 1999;45(3):337–43.
Guth L. “Trophic” influences of nerve on muscle. Physiol Rev. 1968;48(4):645–87.
Bowerman M, Swoboda KJ, Michalski JP, Wang GS, Reeks C, Beauvais A, et al. Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann Neurol. 2012;72(2):256–68.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Research involving human participants
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
An informed consent was obtained from the patient reported.
About this article
Cite this article
Lakkis, B., El Chediak, A., Hashash, J.G. et al. Severe ketoacidosis in a patient with spinal muscular atrophy. CEN Case Rep 7, 292–295 (2018). https://doi.org/10.1007/s13730-018-0345-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-018-0345-y